A detailed history of Nations Financial Group Inc, transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Nations Financial Group Inc, holds 22,500 shares of ANIX stock, worth $80,775. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,500
Previous 15,000 50.0%
Holding current value
$80,775
Previous $46,000 6.52%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$2.21 - $3.35 $16,575 - $25,125
7,500 Added 50.0%
22,500 $49,000
Q2 2023

Aug 14, 2023

BUY
$3.0 - $5.97 $10,500 - $20,895
3,500 Added 30.43%
15,000 $48,000
Q1 2023

May 15, 2023

SELL
$3.86 - $5.0 $5,790 - $7,500
-1,500 Reduced 11.54%
11,500 $49,000
Q4 2022

Feb 07, 2023

BUY
$3.78 - $5.81 $49,140 - $75,530
13,000 New
13,000 $55,000

Others Institutions Holding ANIX

About Anixa Biosciences Inc


  • Ticker ANIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,661,700
  • Market Cap $110M
  • Description
  • Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...
More about ANIX
Track This Portfolio

Track Nations Financial Group Inc, Portfolio

Follow Nations Financial Group Inc, and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nations Financial Group Inc, , based on Form 13F filings with the SEC.

News

Stay updated on Nations Financial Group Inc, with notifications on news.